— Know what they know.
Not Investment Advice

RXST

RxSight, Inc.
1W: -10.3% 1M: -26.3% 3M: -46.1% YTD: -36.5% 1Y: -73.6% 3Y: -57.4%
$6.59
+0.33 (+5.27%)
After Hours: $6.63 (+0.04, +0.61%)
NASDAQ · Healthcare · Medical - Devices · $271.9M · Alpha Radar Strong Sell · Power 27
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$271.9M
52W Range6.32-27.13
Volume705,279
Avg Volume928,313
Beta1.15
Dividend
Analyst Ratings
3 Buy 7 Hold 2 Sell
Consensus Hold
Company Info
CEORonald Kurtz
Employees498
SectorHealthcare
IndustryMedical - Devices
IPO Date2021-07-30
100 Columbia
Aliso Viejo, CA 92656
US
949 521 7830
About RxSight, Inc.

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Recent Insider Trades

NameTypeSharesPriceDate
Gaines Scott M-Exempt 6,261 2026-02-28
Gaines Scott F-InKind 2,580 $7.61 2026-02-28
Gaines Scott M-Exempt 1,500 2026-02-28
Gaines Scott M-Exempt 604 2026-02-28
Gaines Scott M-Exempt 1,250 2026-02-28

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms